Advertisement

The Many Faces of Nonadherence in Adolescents

  • Michael R. Gionfriddo
Chapter

Abstract

Allergic diseases affect millions of adolescents and cause significant morbidity. Effective treatments for these diseases exist; however adolescents sometimes have trouble integrating these treatments into their daily lives. Nonadherence puts the adolescent at risk of poor outcomes ranging from poorly controlled chronic symptoms to life-threatening reactions, or, in rare instances, death. Adolescents’ decisions to adhere to treatment are complex and are often not dependent on any specific factor, but are the result of the interplay of many different variables. Contributing factors include denial of the disease, comorbidities such as anxiety and depression, the perceived severity of the disease and the effectiveness of treatment, knowledge and skills related to disease and treatment, family and peer support, side effects and other treatment-related factors such as cost, and how the treatment can be practically implemented into the daily life of the adolescent through routines and integration to schedules and school policies. Understanding which factors contribute to an adolescent’s adherence can help to individualize management solutions so the adolescent is motivated to adhere and is able to integrate treatment into their daily life.

Keywords

Adherence Asthma Allergies Allergic diseases Adolescent Nonadherence Medication Treatment 

Introduction

Allergic diseases, such as allergic rhinitis, asthma, and eczema, affect millions of adolescents [1, 2, 3, 4]. These conditions cause significant morbidity and mortality. For example, it is estimated that uncontrolled asthma was associated with nearly 14 million missed school days in the United States in 2013 [5]. Many treatments exist which can help manage the symptoms of these diseases and prevent acute exacerbations. Unfortunately, many adolescents have trouble integrating these treatments into their daily lives. As a result of nonadherence, adolescents put themselves at risk of poor outcomes ranging from poorly controlled chronic symptoms to death. For example, children and adolescents who have asthma and lower levels of adherence to controller medications have higher risk of asthma exacerbation [6]. There are many factors which contribute to adolescents’ medication taking behavior. Understanding the many faces of nonadherence can help healthcare professionals, parents, and adolescents develop strategies to successfully integrate treatment into their daily lives, thereby reducing their risk of adverse outcomes and improving their quality of life.

This chapter will review the complex nature of multiple different factors which can all contribute to nonadherence among adolescents with allergic diseases (see Table 4.1). The examples used throughout this chapter will focus on asthma, as this is the allergic condition with the most robust literature and understanding of factors associated with nonadherence. However, many of the principles discussed herein can be applied to other allergic diseases such as allergic rhinitis, atopic dermatitis, and food allergies. The approaches described to address nonadherence in the adolescent patient with asthma can be extrapolated to these other conditions as well.
Table 4.1

Multiple factors involved in nonadherence

Drug factors

Nondrug factors

Improper use of devices (inhalers)

Lack of instruction regarding proper use

Cost of medication

Concern about side effects

Difficult dosing (multiple times/day)

Dissatisfaction with health care professionals

Side effects

Poor supervision, training, or follow-up

Dislike of medication

Anger/denial about condition

Limited access to pharmacy

Underestimation of disease severity

 

Forgetfulness

Clinical Vignettes

Asthma

Susan is a 15-year-old girl. Susan is very competitive and likes to play soccer. Susan also has mild asthma. To manage her asthma, she is prescribed a daily low-dose controller medicine as well as a rescue inhaler. Her asthma is triggered by exercise as well as by seasonal allergies. Her mother reminds her to take her medication, and she is usually good about managing her asthma. Recently, she moved to a new school and has told her mother that “she’s not a kid anymore and doesn’t need to be babied.”

Food Allergies

James is a 13-year-old boy. James likes to hike and play baseball. James is also allergic to peanuts, but he doesn’t like to talk about it. As a precaution James is supposed to carry his epinephrine auto-injector with him at all times. Unfortunately, the auto-injector is very expensive. In addition, James is often “on the go” and frequently forgets to carry his auto-injector with him. Fortunately, James does not have to use it very often. He also finds it difficult to speak up in groups and is reluctant to “announce” that he has a food allergy when going out to restaurants with friends or his baseball team.

Allergic Rhinitis

Mary is an 18-year-old girl. In the spring, Mary graduated from high school and over the summer moved to a new town to start college . Mary has a roommate Beth who has a cat. Recently, Mary was diagnosed with allergic rhinitis. To manage her symptoms, Mary was prescribed a nasal spray. Mary dislikes using the nasal spray and often self-treats with an over-the-counter antihistamine. The antihistamine, however, often makes her drowsy, so she often goes without and experiences symptoms as a result. Beth also lets her cat go throughout their apartment, including on Mary’s bed.

Factors Which Affect Adolescents’ Treatment Adherence Behavior

An adolescent’s ability to adhere to treatment is challenging and often not dependent upon any specific factor, but ultimately the result of many different factors contributing to one another (see Fig. 4.1). These factors include the adolescent’s self-perception, their condition, the treatments prescribed to manage their condition, and their understanding of others’ (e.g., family, friends, community, society) perceptions. In addition to their personal perceptions, the knowledge or skills of the adolescent contribute to their ability to adhere, as does their ability to make treatment part of their routine and integrate it into their busy schedules. Intrinsic factors related to the condition or the treatment, such as a medication’s propensity for causing undesirable effects, also affect adolescents’ decision-making. Finally, factors external to the adolescent, such as school policies, affect adolescents’ abilities to adhere to their prescribed treatment regimens.
Fig. 4.1

Factors affecting adherence in the adolescent with an allergic disease

Personal Factors

Denial and Depression

The manner in which an adolescent views their self, their illness, and their place in the world may affect their ability to adhere to medications. Allergic diseases, while often diagnosed by a healthcare provider, are experienced first by the adolescent. The meaning or etiology the adolescent applies to these symptoms may not match those of the medical establishment. The adolescent may deny that they have the disease. For some, this may be due to differing illness narratives, where the adolescent attributes their symptoms to a different illness [7]. In asthma, for example, parental illness models which differ from those of the medical establishment may contribute to nonadherence [8, 9].

Adolescents may also deny they have the illness altogether [10, 11]. This has been found in studies of adults with asthma, where issues such as stigma and negative perceptions of the illness contributed to denial [10]. The negative connotations associated with the label of “asthma” made it such that individuals did not want to accept it as part of their identity. These feelings affected behavior, with those who denied or distanced themselves from asthma unlikely to adhere to medication use because to some, taking the medication would be synonymous with accepting that they have asthma. This finding has been confirmed among adolescents [12, 13, 14, 15]. As one adolescent stated in a focus group: “It’s like, trying to escape from it. Like, maybe if I don’t have to take the medicine it’ll go away, or like if I take the medicine then I’m like accepting the fact that I have this” [14].

Adolescents may also have views of medications which do not promote adherence. A general dislike of medications is common [11]. Some adolescents with asthma may also hold these views, which contributes to nonadherence [15, 16]. As one adolescent stated: “I don’t think it’s [taking medications] a good idea and it’s really degrading like taking pills all the time… It like makes you feel ill, it’s a reminder sitting there saying you’re ill and it’s not nice , it puts you down taking pills” [15].

In addition to adolescents’ views of their illness and treatments, their views regarding themselves and their place in the world may affect their ability to manage their treatment regimens. Specifically, depression and anxiety have been linked to lower levels of medication adherence, including in asthma [17, 18, 19, 20]. This link has been explored in adolescents with asthma; however, the relationship between asthma, depression, anxiety, and adherence is still unclear [21, 22, 23]. While further work needs to be done to clarify this relationship, clinicians treating adolescents with asthma should monitor for symptoms of depression and anxiety and manage appropriately, as depression and anxiety have been independently associated, although not consistently, with worse asthma control and more exacerbations [20, 23, 24, 25].

Perceived Threat of Condition

Many adolescents explore their independence through taking risks, including nonadherence to treatment for their allergic disease [21]. Contributing to this risk-taking behavior is a sense that the disease is not a threat. For example, among a sample of adolescents with food allergies, those who perceived their allergy to be more severe were more likely to be adherent to self-care behaviors, such as carrying their auto-injector with them (OR = 1.24 95% CI 1.01–1.52) [26]. Another study of young adults with asthma found that the most common reason for nonadherence was lack of perceived need, driven mostly by a feeling that they felt well without using the medication [27]. Similarly, qualitative studies have found that some adolescents link the severity of asthma with the necessity for using medications [14, 28, 29, 30]. For example, one adolescent discussed how her asthma wasn’t as bad as others, and as a result she doesn’t need to take her medication: “I think people have it [asthma] a lot worse than me and it’s like I just like don’t need it [corticosteroid inhaler] sometimes and I can go, I can go a few days without it…” [28].

For some adolescents, the threat of the disease wanes over time. In these situations, nonadherence may transition from an unintentional (i.e., forgetting) to a more active or intentional process as they experiment with whether or not they need the medications [12, 13, 28, 31]. In some cases, the adolescent stops taking their medicine altogether, but in other cases, this process of experimentation reinforces the need to take their medicine. For example, one adolescent stated: “When I first started it was OK but then I forgot a couple of times, and then I couldn’t be bothered to do it, to try and remember. I thought, ‘oh no, it’s not worth it, I’m alright, you know, I don’t need it.’ But I’ve found out since I’ve been taking it that’s it’s really helped me…” [31].

Perceived Value of Treatment

While for some adolescents, the threat of the disease can affect adherence, for others a contributor to nonadherence is uncertainty around the effectiveness or value of the treatment. If adolescents believe that the treatment is ineffective, they are less likely to adhere to the medication [12, 32, 33, 34, 35, 36]. For example, in one study, one adolescent described how he felt his inhalers worked so he took them, while he felt his other medicines did not work so he often forgot to take them: “I don’t usually forget to take my inhalers cos I know that they help, I can’t really feel the tablets helping so I usually forget to take them” [32].

Knowledge and Skills

Knowledge contributes to how an adolescent views their disease and treatment. Many adolescents often have misconceptions that may contribute to nonadherence. While there is some inconsistency [37], the literature appears to support a link between knowledge and adherence [22, 37, 38]. A reason for this inconsistency may be due to whether the parent of the adolescent was questioned about knowledge, as well as the shared responsibility for asthma management that occurs between adolescents and their caregivers. The difficulty in measuring knowledge likely also contributes to this discrepancy [39]. However, there is evidence that adolescents may have knowledge of asthma and yet fail to act on that knowledge [40, 41]. In these situations, other barriers, such as forgetfulness, may affect an adolescent’s ability to adhere to medication [12, 36].

One example of how knowledge can contribute to nonadherence is a lack of understanding surrounding the differences between preventer or controller medications such as inhaled corticosteroids and reliever medications such as short-acting β-agonists [14, 32]. Such confusion may prove harmful for adolescents as they fail to gain the full benefit of controller medications, such as inhaled corticosteroids, if they use them on only an as-needed basis when they have symptoms [14, 42]. While this strategy in particular can be an effective treatment strategy for some specific patients [43], using controller medications on an as-needed basis is a common form of nonadherence.

Another example of a common misunderstanding that may influence medication adherence in asthma is the belief that, rather than being a chronic illness, asthma is something which is acute and episodic, exemplified by the phrase “no symptoms, no asthma” [44], or something that could be “outgrown” [14, 40, 45]. This belief tends to minimize the importance of controller medications to help prevent symptoms of asthma, which can then lead to reliance or overuse of reliever medication [31]. For some, this was an intentional behavior, as one boy stated: “I’ll take it [medication] when I feel symptoms” [9]. Yet, for others, symptoms served as a reminder to take medications, and therefore a lack of symptoms led to forgetting to take the medication [46].

An important component of adherence is not only taking the medication but taking it correctly [47]. Incorrect use of medication can include taking it more or less often than prescribed, using doses different from what was prescribed, and, with asthma in particular, incorrect inhaler technique. Many adolescents with asthma struggle with incorrect inhaler technique [48, 49], which has been associated with higher rates of hospitalizations and lower rates of asthma control [49, 50]. While several interventions have been tested to improve asthma inhaler technique, it is currently unclear which approach is best, especially among adolescents [51]. Regardless, clinicians should assess inhaler technique regularly and educate adolescents on the appropriate technique, along with the opportunity to practice in the office setting with a trainer device (or their own inhaler). Adolescents should be encouraged to communicate with their clinician if they are not confident or have questions regarding their inhaler technique [52].

Social Factors

Family

Family has an important influence on adolescents’ medication taking behavior. This influence can either positively or negatively affect medication adherence. Parental illness beliefs were highlighted above as a potential factor influencing adolescents’ adherence [8, 9], but other factors can also affect adherence , such as parental beliefs about medications [53, 54].

Adolescence is a time of transition where the adolescent grows increasingly independent, including in the management of their health. However, adolescents often continue to rely on their parents for support in managing their health during this transition [55]. While one study found no difference in adherence based upon level of family support [56], several studies have highlighted the importance parental support can play in promoting adherence. For example, adolescents often rely on their parents to remind them to take their medication [9, 12, 32, 35, 36, 55, 57, 58]. As one adolescent stated: “I take them by myself but my mom has to remind me otherwise I don’t do it” [32]. For some adolescents these reminders were annoying but still useful: “… [My mother reminding me] gets annoying, but it helps because I don’t forget…” [35]. This strategy, however, can also be counterproductive as the adolescent attempts to assert their independence. In a few studies, adolescents reported that they lied about medication use [32, 55]. Sometimes this is done out of laziness . As one adolescent stated: “Sometimes, most of the time my mum says, ‘have you took it’ and I just can’t be bothered to go and take it but I say I have so she don’t get worried, well I can’t really be bothered if I am walking to the kitchen, so I just tell her I have” [32]. Other times, it is about asserting independence: “It’s rather annoying my mother asking me daily if I’ve taken my Flixotide. What’s that got to do with her? I don’t want get mixed up in her problems either. I’ll take it when I feel symptoms” [9].

As the adolescent transitions toward independence, more responsibility is placed upon them for managing their disease. During this transition, however, the management of the disease may suffer as tasks previously delegated to the parent are taken on by the adolescent [40, 59]. For example, monitoring the amount of medication and requesting a refill when necessary [40], or adhering to medication: “My mother used to be like you know you got to do your inhaler, use the machine before you go out and so she would prevent it from happening, but now I just wait for it to happen…” [59]. During this transitionary period, care must be given to both support the adolescent and at the same time allow them to take on more responsibility. The amount of support given should be gauged on an individual level and based upon factors such as willingness to accept responsibility, maturity, and knowledge of asthma and asthma medications and not based upon age. Clinicians and parents should also recognize that the adolescent’s need for support may fluctuate based upon their situation, as well as over time. For example, during particularly busy or stressful times, or if the adolescent begins to suffer from anxiety or depression, additional support may need to be given to maintain adherence and disease control.

Peers

Like family, peers can also either have a positive or negative influence on adolescents’ adherence behavior. While peers can be supportive and promote adherence behavior [13, 33, 60, 61], they can also have the opposite effect [56]. Additionally, perceived or actual stigmatization of the adolescent with an allergic disease by their peers may negatively affect adherence. Many adolescents desire to be viewed as “normal,” and having the allergic condition sets them apart, which can lead them to be labeled as “abnormal,” either by themselves or others [30, 34, 62]. In conditions such as asthma, use of medication in public may also set them apart. While not universal [14, 31, 33, 63], many adolescents with asthma report being embarrassed to take their inhalers in public, and as a result they either hide to take their medicine or avoid taking it in public altogether [13, 34, 58, 60, 64, 65, 66, 67]. As one adolescent stated: “It was very embarrassing for me to take my inhaler. People know about asthma, and yet they treat you weird. I used to hide myself taking my inhaler because I hated it when people looked at me. I felt offended, I felt ashamed” [66].

Treatment-Related Factors

Side Effects

Side effects related to treatments for allergic diseases can negatively affect medication adherence. Inhaled corticosteroids, a common treatment for asthma, have been associated with a variety of side effects, including dysphonia (difficulty speaking), infection (especially oral infection such as oral candidiasis), cough, osteoporosis, cataracts, and impaired growth [52]. Some adolescents may also experience weight gain if they require oral systemic corticosteroids [52, 64]. For some, side effects may be so bothersome or severe that they discontinue therapy [12, 32, 33, 59, 64, 66, 68]. As one adolescent stated: “When I’m reaping all the side effects and I was just thinking, you know, nuts to this, look at me I’m a mess and asthma is ok I’m just not gonna take them for a while to see what happens” [32].

The main treatment for the immediate relief of asthma symptoms, short-acting β-agonists, is also associated with side effects. The most common side effects include tremor and tachycardia [52]. Adolescents sometimes also report anxiety or feeling “hyper,” which may contribute to nonadherence [34]. In addition to the abovementioned side effects, some adolescents were concerned about becoming dependent or addicted to the medication [29, 33], while others complained that the inhalers have a bad taste and this contributed to their decisions to be nonadherent [29, 33, 46, 59, 63].

Cost

The treatments for allergic diseases can often be expensive. While many adolescents do not directly pay for their medications, they can be sensitive to the pressures that cost may place upon their family. This can sometimes lead to adolescents rationing their medication to avoid having to refill the medication as frequently [14, 58]. Other adolescents and their families can simply not afford the medication or face other barriers to accessing the medication (e.g., transportation) [14, 45, 66]. Clinicians should explore the extent to which cost is a concern for the adolescent and their family, and when possible, prescribe less expensive alternatives. In situations where this is not possible, focusing on non-pharmacologic approaches to manage the disease (e.g., breathing exercises in asthma), or connecting the adolescent and their family with resources which may help cover the cost of the prescriptions, may help to facilitate adherence.

Structural Factors

Schedules and Routines

Adolescents often have busy schedules. Some adolescents can incorporate disease management into their routines, which facilitates adherence [12, 13, 63], while others cannot. Even among adolescents who incorporate disease management into their routines, when their routines get disrupted, nonadherence may result. For example, if the adolescent is running late for school, they may end up forgetting their medication in their haste to catch the bus, or prioritize getting to school over taking their medication, especially if it is perceived as being time consuming [14, 16, 32, 34, 46, 57, 60, 63]. As one adolescent stated: “Sometimes I forget… Because like when I’m getting ready for school, I have to try and get my breakfast and my stuff packed and my bag down by the door and get dressed and all that stuff, so I hardly have time for puffers” [46].

School Policies

In qualitative studies of adolescents with asthma, several adolescents described situations where school policies were not conducive to adhering to their medications [59, 69, 70]. For example, adolescents may not be allowed to carry their medication with them and may have to either keep it in their locker or keep it stored in the nurse’s or administrator’s office. In these situations, adolescents may experience distressing symptoms without access to relief, as one adolescent recalled: “I was in PE and having trouble breathing and [the teacher] said ‘Well, we’re almost done so just wait a minute,’ and she wouldn’t let me go inside to get my inhaler” [70]. Clinicians and parents should understand local school policies as it relates to medication to ensure that adolescents have timely access to medication to facilitate both optimal medication adherence as well as the least amount of symptoms or distress possible.

Conclusion

Nonadherence in adolescents with allergic diseases is not a simple behavior. There are many factors which contribute to nonadherence in the adolescent. Many times, nonadherence is unintentional, such as when the adolescent forgets to take the medication, which has a variety of causes, but could also be intentional due to factors such as dislike of medicine, not believing the disease is a threat, or not finding the medication to be effective. Understanding adolescents’ reasons for nonadherence, either intentional or unintentional, is a helpful first step to tailor strategies to help overcome barriers to adherence and facilitate integration of the treatment into the adolescent’s daily life.

References

  1. 1.
    Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2 Suppl):S1–84.CrossRefPubMedGoogle Scholar
  2. 2.
    Jackson KD, Howie LD, Akinbami LJ. Trends in allergic conditions among children: United States, 1997–2011. NCHS Data Brief. 2013;121:1–8.Google Scholar
  3. 3.
    Akinbami LJ, Moorman JE, Bailey C, Zahran HS, King M, Johnson CA, et al. Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010. NCHS Data Brief. 2012;94:1–8.Google Scholar
  4. 4.
    Silverberg JI, Simpson EL. Associations of childhood eczema severity: a US population-based study. Dermatitis. 2014;25(3):107–14.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    National Center for Environmental Health. AsthmaStats: asthma-related missed school days among children aged 5-17 Years. Centers for disease control and prevention; 2015. https://www.cdc.gov/asthma/asthma_stats/missing_days.htm
  6. 6.
    Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MC, Verhamme KM. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45(2):396–407.CrossRefPubMedGoogle Scholar
  7. 7.
    Kleinman A, Eisenberg L, Good B. Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med. 1978;88(2):251–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Yoos HL, Kitzman H, Henderson C, McMullen A, Sidora-Arcoleo K, Halterman JS, et al. The impact of the parental illness representation on disease management in childhood asthma. Nurs Res. 2007;56(3):167–74.CrossRefPubMedGoogle Scholar
  9. 9.
    van Dellen QM, van Aalderen WM, Bindels PJ, Ory FG, Bruil J, Stronks K. Asthma beliefs among mothers and children from different ethnic origins living in Amsterdam, the Netherlands. BMC Public Health. 2008;8:380.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Adams S, Pill R, Jones A. Medication, chronic illness and identity: the perspective of people with asthma. Soc Sci Med. 1997;45(2):189–201.CrossRefPubMedGoogle Scholar
  11. 11.
    Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–55.CrossRefPubMedGoogle Scholar
  12. 12.
    Buston KM, Wood SF. Non-compliance amongst adolescents with asthma: listening to what they tell us about self-management. Fam Pract. 2000;17(2):134–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Kintner E. Adolescent process of coming to accept asthma: a phenomenological study. J Asthma. 1997;34(6):547–61.CrossRefPubMedGoogle Scholar
  14. 14.
    Wamboldt FS, Bender BG, Rankin AE. Adolescent decision-making about use of inhaled asthma controller medication: results from focus groups with participants from a prior longitudinal study. J Asthma. 2011;48(7):741–50.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Shaw A, Thompson EA, Sharp D. Complementary therapy use by patients and parents of children with asthma and the implications for NHS care: a qualitative study. BMC Health Serv Res. 2006;6:76.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Panzera AD, Schneider TK, Martinasek MP, Lindenberger JH, Couluris M, Bryant CA, et al. Adolescent asthma self-management: patient and parent-caregiver perspectives on using social media to improve care. J Sch Health. 2013;83(12):921–30.CrossRefPubMedGoogle Scholar
  17. 17.
    World Health Organization. Adherence to long-term therapies: evidence for action. 2003. http://www.who.int/chp/knowledge/publications/adherence_report/en/
  18. 18.
    DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Grenard JL, Munjas BA, Adams JL, Suttorp M, Maglione M, McGlynn EA, et al. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med. 2011;26(10):1175–82.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Krauskopf KA, Sofianou A, Goel MS, Wolf MS, Wilson EA, Martynenko ME, et al. Depressive symptoms, low adherence, and poor asthma outcomes in the elderly. J Asthma. 2013;50(3):260–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Bender BG. Risk taking, depression, adherence, and symptom control in adolescents and young adults with asthma. Am J Respir Crit Care Med. 2006;173(9):953–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Mosnaim G, Li H, Martin M, Richardson D, Belice PJ, Avery E, et al. Factors associated with levels of adherence to inhaled corticosteroids in minority adolescents with asthma. Ann Allergy Asthma Immunol. 2014;112(2):116–20.CrossRefPubMedGoogle Scholar
  23. 23.
    Shams MR, Bruce AC, Fitzpatrick AM. Anxiety contributes to poorer asthma outcomes in Inner-City black adolescents. J Allergy Clin Immunol Pract. 2018;6(1):227–35.CrossRefPubMedGoogle Scholar
  24. 24.
    Sumino K, O’Brian K, Bartle B, Au DH, Castro M, Lee TA. Coexisting chronic conditions associated with mortality and morbidity in adult patients with asthma. J Asthma. 2014;51(3):306–14.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Zhang L, Zhang X, Zheng J, Wang L, Zhang HP, Wang L, et al. Co-morbid psychological dysfunction is associated with a higher risk of asthma exacerbations: a systematic review and meta-analysis. J Thorac Dis. 2016;8(6):1257–68.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Jones CJ, Llewellyn CD, Frew AJ, Du Toit G, Mukhopadhyay S, Smith H. Factors associated with good adherence to self-care behaviours amongst adolescents with food allergy. Pediatr Allergy Immunol. 2015;26(2):111–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Axelsson M. Personality and reasons for not using asthma medication in young adults. Heart Lung. 2013;42(4):241–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Callery P, Milnes L, Verduyn C, Couriel J. Qualitative study of young people’s and parents’ beliefs about childhood asthma. Br J Gen Pract. 2003;53(488):185–90.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Naimi DR, Freedman TG, Ginsburg KR, Bogen D, Rand CS, Apter AJ. Adolescents and asthma: why bother with our meds? J Allergy Clin Immunol. 2009;123(6):1335–41.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Rydstrom I, Hartman J, Segesten K. Not letting the disease get the upper hand over life: strategies of teens with asthma. Scand J Caring Sci. 2005;19(4):388–95.CrossRefPubMedGoogle Scholar
  31. 31.
    Williams C. Doing health, doing gender: teenagers, diabetes and asthma. Soc Sci Med. 2000;50(3):387–96.CrossRefPubMedGoogle Scholar
  32. 32.
    Edgecombe K, Latter S, Peters S, Roberts G. Health experiences of adolescents with uncontrolled severe asthma. Arch Dis Child. 2010;95(12):985–91.CrossRefPubMedGoogle Scholar
  33. 33.
    Gabe J, Bury M, Ramsay R. Living with asthma: the experiences of young people at home and at school. Soc Sci Med. 2002;55(9):1619–33.CrossRefPubMedGoogle Scholar
  34. 34.
    Penza-Clyve SM, Mansell C, McQuaid EL. Why don’t children take their asthma medications? A qualitative analysis of children’s perspectives on adherence. J Asthma. 2004;41(2):189–97.CrossRefPubMedGoogle Scholar
  35. 35.
    Laster N, Holsey CN, Shendell DG, McCarty FA, Celano M. Barriers to asthma management among urban families: caregiver and child perspectives. J Asthma. 2009;46(7):731–9.CrossRefPubMedGoogle Scholar
  36. 36.
    Koster ES, Philbert D, de Vries TW, van Dijk L, Bouvy ML. “I just forget to take it”: asthma self-management needs and preferences in adolescents. J Asthma. 2015;52(8):831–7.CrossRefPubMedGoogle Scholar
  37. 37.
    Drotar D, Bonner MS. Influences on adherence to pediatric asthma treatment: a review of correlates and predictors. J Dev Behav Pediatr. 2009;30(6):574–82.CrossRefPubMedGoogle Scholar
  38. 38.
    Koster ES, Philbert D, Winters NA, Bouvy ML. Adolescents’ inhaled corticosteroid adherence: the importance of treatment perceptions and medication knowledge. J Asthma. 2015;52(4):431–6.CrossRefPubMedGoogle Scholar
  39. 39.
    Ho J, Bender BG, Gavin LA, O’Connor SL, Wamboldt MZ, Wamboldt FS. Relations among asthma knowledge, treatment adherence, and outcome. J Allergy Clin Immunol. 2003;111(3):498–502.CrossRefPubMedGoogle Scholar
  40. 40.
    Velsor-Friedrich B, Vlasses F, Moberley J, Coover L. Talking with teens about asthma management. J Sch Nurs. 2004;20(3):140–8.CrossRefPubMedGoogle Scholar
  41. 41.
    Simon L. Urban Youth’s perspectives on asthma and asthma management. J Asthma Allergy Educ. 2013;4(3):103–11.CrossRefGoogle Scholar
  42. 42.
    Gibson-Scipio W, Gourdin D, Krouse HJ. Asthma self-management goals, beliefs and behaviors of urban African American adolescents prior to transitioning to adult health care. J Pediatr Nurs. 2015;30(6):e53–61.CrossRefPubMedGoogle Scholar
  43. 43.
    Gionfriddo MR, Hagan JB, Hagan CR, Volcheck GW, Castaneda-Guarderas A, Rank MA. Stepping down inhaled corticosteroids from scheduled to as needed in stable asthma: systematic review and meta-analysis. Allergy Asthma Proc. 2015;36(4):262–7.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Halm EA, Mora P, Leventhal H. No symptoms, no asthma: the acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma. Chest. 2006;129(3):573–80.CrossRefPubMedGoogle Scholar
  45. 45.
    Munro JF, Haire-Joshu D, Fisher EB, Wedner HJ. Articulation of asthma and its care among low-income emergency care recipients. J Asthma. 1996;33(5):313–25.CrossRefPubMedGoogle Scholar
  46. 46.
    Parsons K, Worrall G, Knight J, Hewitt D. Inhaler therapy. What it means for children with asthma. Can Fam Physician. 2004;50:1102–8.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Boulet LP, Vervloet D, Magar Y, Foster JM. Adherence: the goal to control asthma. Clin Chest Med. 2012;33(3):405–17.CrossRefPubMedGoogle Scholar
  48. 48.
    Scarfone RJ, Capraro GA, Zorc JJ, Zhao H. Demonstrated use of metered-dose inhalers and peak flow meters by children and adolescents with acute asthma exacerbations. Arch Pediatr Adolesc Med. 2002;156(4):378–83.CrossRefPubMedGoogle Scholar
  49. 49.
    Capanoglu M, Dibek Misirlioglu E, Toyran M, Civelek E, Kocabas CN. Evaluation of inhaler technique, adherence to therapy and their effect on disease control among children with asthma using metered dose or dry powder inhalers. J Asthma. 2015;52(8):838–45.CrossRefPubMedGoogle Scholar
  50. 50.
    Westerik JA, Carter V, Chrystyn H, Burden A, Thompson SL, Ryan D, et al. Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting. J Asthma. 2016;53(3):321–9.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Normansell R, Kew KM, Mathioudakis AG. Interventions to improve inhaler technique for people with asthma. Cochrane Database Syst Rev. 2017;3:Cd012286.PubMedGoogle Scholar
  52. 52.
    Global Initative for Asthma. Global strategy for asthma management and prevention. 2017. http://ginasthma.org/wp-content/uploads/2016/01/wms-GINA-2017-main-report-tracked-changes-for-archive.pdf
  53. 53.
    McQuaid EL, Everhart RS, Seifer R, Kopel SJ, Mitchell DK, Klein RB, et al. Medication adherence among Latino and Non-Latino white children with asthma. Pediatrics. 2012;129(6):e1404–e10.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Conn KM, Halterman JS, Fisher SG, Yoos HL, Chin NP, Szilagyi PG. Parental beliefs about medications and medication adherence among urban children with asthma. Ambul Pediatr. 2005;5(5):306–10.CrossRefPubMedGoogle Scholar
  55. 55.
    Ayala GX, Miller D, Zagami E, Riddle C, Willis S, King D. Asthma in middle schools: what students have to say about their asthma. J Sch Health. 2006;76(6):208–14.CrossRefPubMedGoogle Scholar
  56. 56.
    Chen E, Chim LS, Strunk RC, Miller GE. The role of the social environment in children and adolescents with asthma. Am J Respir Crit Care Med. 2007;176(7):644–9.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Blaakman SW, Cohen A, Fagnano M, Halterman JS. Asthma medication adherence among urban teens: a qualitative analysis of barriers, facilitators and experiences with school-based care. J Asthma. 2014;51(5):522–9.CrossRefPubMedGoogle Scholar
  58. 58.
    Slack MK, Brooks AJ. Medication management issues for adolescents with asthma. Am J Health Syst Pharm. 1995;52(13):1417–21.PubMedGoogle Scholar
  59. 59.
    Martin M, Beebe J, Lopez L, Faux S. A qualitative exploration of asthma self-management beliefs and practices in Puerto Rican families. J Health Care Poor Underserved. 2010;21(2):464–74.CrossRefPubMedGoogle Scholar
  60. 60.
    Sepponen K, Ahonen R, Vaskilampi T. Children’s perceptions of the use of asthma medicines – a qualitative interview study among Finnish children with asthma. J Soc Adm Pharm. 2003;20(3):92–102.Google Scholar
  61. 61.
    Rhee H, Wyatt TH, Wenzel JA. Adolescents with asthma: learning needs and internet use assessment. Respir Care. 2006;51(12):1441–9.PubMedGoogle Scholar
  62. 62.
    Rydstrom I, Englund AC, Sandman PO. Being a child with asthma. Pediatr Nurs. 1999;25(6):589–90, 93-6.PubMedGoogle Scholar
  63. 63.
    van Es SM, le Coq EM, Brouwer AI, Mesters I, Nagelkerke AF, Colland VT. Adherence-related behavior in adolescents with asthma: results from focus group interviews. J Asthma. 1998;35(8):637–46.CrossRefPubMedGoogle Scholar
  64. 64.
    Rich M, Chalfen R. Showing and telling asthma: children teaching physicians with visual narrative. Vis Sociol. 1999;14(1):51–71.CrossRefGoogle Scholar
  65. 65.
    Cordina M, Hughes C, McElnay J. Health-related issues of importance to school children with asthma-a qualitative study. J Soc Adm Pharm. 2002;19(5):162–70.Google Scholar
  66. 66.
    Rich M, Patashnick J, Chalfen R. Visual illness narratives of asthma: explanatory models and health-related behavior. Am J Health Behav. 2002;26(6):442–53.CrossRefPubMedGoogle Scholar
  67. 67.
    Rhee H, Wenzel J, Steeves RH. Adolescents’ psychosocial experiences living with asthma: a focus group study. J Pediatr Health Care. 2007;21(2):99–107.CrossRefPubMedGoogle Scholar
  68. 68.
    Steven K, Marsden W, Neville RG, Hoskins G, Sullivan FM, Drummond N. Do the British guidelines for asthma management facilitate concordance? Health Expect. 2004;7(1):74–84.CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    Newbould J, Francis SA, Smith F. Young people’s experiences of managing asthma and diabetes at school. Arch Dis Child. 2007;92(12):1077–81.CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Horner SD. Asthma self-care: just another piece of school work. Pediatr Nurs. 1999;25(6):597–600-4.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Center for Pharmacy Innovation and OutcomeGeisingerDanvilleUSA

Personalised recommendations